Correction to: Cancer Gene Therapy
A mistake in the beta-actin control in Fig. 4B and an unnecessary inclusion of an extra Erk1/2 control sample in Fig. 6A, B were made in the initial publication. None of these mistakes affects the main finding and conclusion of the publication.
Specifically
In Fig. 4B, during the step of original film scanning (we have three different exposures of each gel/membrane), organizing and copying-and-pasting different images to form the Fig. 4B, careless mistakes were made in re-using two different exposures of Akt2 for beta-actin, instead of beta-actin blots themselves. Corrections have now been made to replace them with the original beta-actin blots.
In Fig. 6A, B, the original experiment of anti-Erk1/2 immunoblots had a seventh lane loaded with total lysates from WT MDA-MB-231 cells, which was unrelated to this publication. We mistakenly included all seven samples (panels b and f), while other control markers in the same experiment, Akt2, Stat3 and beta-actin had six samples. Correction has now been made to remove the seventh sample from the anti-Erk1/2 immunoblots.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, X., Chang, C., Hao, M. et al. Correction to: Heat shock protein-90alpha (Hsp90α) stabilizes hypoxia-inducible factor-1α (HIF-1α) in support of spermatogenesis and tumorigenesis. Cancer Gene Ther 28, 1071–1072 (2021). https://doi.org/10.1038/s41417-021-00330-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41417-021-00330-8